3.36
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
40.64%
61.20
|
43.52 | 94.97 | 50.63 | 50.87 |
| Operating Income/Loss |
40.64%
-61.20
|
-43.52 | -94.97 | -50.63 | -50.87 |
| Income/Loss From Continuing Operations Before Tax |
39.55%
-58.83
|
-42.15 | -93.80 | -49.39 | -49.07 |
| Income/Loss From Continuing Operations After Tax |
39.55%
-58.83
|
-42.15 | -93.80 | -49.39 | -49.07 |
|
|
39.55%
-58.83
|
-42.15 | -93.80 | -49.39 | -49.07 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.06%
7.654
|
260.49 | 238.41 | 237.58 | 1.815 |
| Diluted Average Shares |
97.06%
7.654
|
260.49 | 238.41 | 237.58 | 1.815 |
| Basic Earnings Per Share |
31.25%
-0.21
|
-0.16 | -0.39 | -0.21 | -0.21 |
| Diluted Earnings Per Share |
31.25%
-0.21
|
-0.16 | -0.39 | -0.21 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):